This suggests that NEDD8 may be a potential therapeutic target in HPV+ cancers by preventing CRL activation and the interaction of E7 with pRb; as such, inhibition of the NEDD8 activating enzyme (NAE) with MLN4924 prevents E7-mediated pRb degradation [60]. The gene discussed is RB1; the disease is cancer.